724 results about "Motion artifacts" patented technology

Disclosed herein are biointerface membranes including a macro-architecture and a micro-architecture co-continuous with and bonded to and/or located within at least a portion of the macro-architecture. The macro- and micro-architectures work together to manage and manipulate the high-level tissue organization and the low-level cellular organization of the foreign body response in vivo, thereby increasing neovascularization close to a device-tissue interface, interfering with barrier cell layer formation, and providing good tissue anchoring, while reducing the effects of motion artifact, and disrupting the organization and/or contracture of the FBC. The biointerface membranes of the preferred embodiments can be utilized with implantable devices such as devices for the detection of analyte concentrations in a biological sample (for example, from a body), cell transplantation devices, drug delivery devices, electrical signal delivering or measuring devices, and/or combinations thereof.

This invention provides methods and systems for the analysis of data returned from monitoring multiple physiological parameters of a subject, especially from ambulatory multiple parameter monitoring. The methods and systems remove motion artifacts from signals and separate multiple components of single signals due to two or more physiological systems or processes. Each output signal is are preferably free from motion artifacts and reflects primarily functioning of only a single physiological system or process.

The present invention is directed toward a pulse oximetry system for the determination of a physiological parameter capable of removing motion artifacts from physiological signals comprises a hardware subsystem and a software subsystem. The software subsystem is used in conjunction with the hardware subsystem to perform a method for removing a plurality of motion artifacts from the photo-plethysmographic data and for obtaining a measure of at least one physiological parameter from the data. The method comprises acquiring the raw photo-plethysmographic data, transforming the data into the frequency domain, analyzing the transformed data to locate a series of candidate cardiac spectral peaks (primary plus harmonics), reconstructing a photo-plethysmographic signal in the time domain with only the candidate cardiac spectral peaks (primary plus harmonics), computing the second order derivative of the reconstructed photo-plethysmographic signal, analyzing the candidate second order derivative photo-plethysmographic signal to determine the absence or presence of cardiac physiologic signal characteristics, and finally selecting the best physiologic candidate from the series of potential cardiac spectral peaks (primary plus harmonics) based upon a second derivative scoring system. This scoring system is preferentially based upon second derivative processing analysis, but can be equally applied using the first, third, fourth or other similar derivative processing analysis.

A method and an apparatus for measuring a physiological parameter, functioning based on obtaining a first signal derived from electromagnetic energy transmitted through a tissue portion at a first wavelength, the first signal including a signal portion corresponding with motion-related events and a signal portion corresponding with arterial pulsation events, where at the first wavelength water is a dominant absorber of electromagnetic energy in the tissue portion; obtaining a second signal derived from electromagnetic energy transmitted through a tissue portion at a second wavelength, the second signal including a signal portion corresponding with motion-related events and a signal portion corresponding with arterial pulsation events, where at the second wavelength hemoglobin is a dominant absorber of electromagnetic energy in the tissue portion; and combining the first signal and the second signal to generate a combined plethysmograph signal, such that the combined signal has a signal portion corresponding with motion-related events that is smaller than that present in the first signal or the second signal.

A subcutaneous implantable cardioverter defibrillator (SubQ ICD) includes a housing carrying electrodes for sensing ECG signals and delivering therapy. A sensor detects local motion in the area of the housing and produces a noise signal related to motion artifact noise contained in ECG signals derived from the electrode array. An adaptive noise cancellation circuit enhances ECG signals based on the local motion noise signal. A therapy delivery circuit delivers cardioversion and defibrillation pulses based upon the enhanced ECG signals.

Real time, high-speed image stabilization with a retinal tracking scanning laser ophthalmoscope (TSLO) enables new approaches to established diagnostics. Large frequency range (DC to 19 kHz), wide-field (40-deg) stabilized Doppler flowmetry imaging is described for human subjects. The fundus imaging method is a quasi-confocal line-scanning laser ophthalmoscope (LSLO). The retinal tracking system uses a confocal reflectometer with a closed loop optical servo system to lock onto features in the ocular fundus and automatically re-lock after blinks. By performing a slow scan with the laser line imager, frequency-resolved retinal perfusion and vascular flow images can be obtained free of eye motion artifacts.

An electrode system for reducing noise from an electronic signal, the system including an electrode that provides the electronic signal, and a sensor that senses motion and provides a motion signal. The electrode system includes a controller that determines a noise value based on an analysis of the motion signal, and subtracts the noise value from the electronic signal. The electrode system can reduce or eliminate motion artifact from an electronic signal that can result in misdiagnosis, prolong procedural duration and inappropriate treatment of a patient.

A method for removing motion artifacts from devices for sensing bodily parameters and apparatus and system for effecting same. The method includes analyzing segments of measured data representing bodily parameters and possibly noise from motion artifacts. Each segment of measured data may correspond to a single light signal transmitted and detected after transmission or reflection through bodily tissue. Each data segment is frequency analyzed to determine up to three candidate peaks for further analysis. Each of the up to three candidate frequencies may be filtered and various parameters associated with each of the up to three candidate frequencies are calculated. The best frequency, if one exists, is determined by arbitrating the candidate frequencies using the calculated parameters according to predefined criteria. If a best frequency is found, a pulse rate and SPO₂ may be output. If a best frequency is not found, other, conventional techniques for calculating pulse rate and SpO₂ may be used. The above method may be applied to red and infrared pulse oximetry signals prior to calculating pulse rate and/or pulsatile blood oxygen concentration. Apparatus and systems disclosed are configured to perform methods disclosed according to the invention.

A sensor for pulse oximetry or other applications utilizing spectrophotometry may be adapted to reduce motion artifacts by fixing the optical distance between an emitter and detector. A flexible sensor is provided with a stiffening member to hold the emitter and detector of the sensor in a relatively fixed position when applied to a patient. Further, an annular or partially annular sensor is adapted to hold an emitter and detector of the sensor in a relatively fixed position when applied to a patient. A clip-style sensor is provided with a spacer that controls the distance between the emitter and detector.

A new PPG/SpO₂ based ear hook sensor was constructed with the PPG/SpO₂ sensors are attached to the skin in the regions of superficial artery and vein (010) and posterior auricular artery and vein around the ear (011 of FIG. 1C). An ear wearable heart rate monitor is constructed with PPG/SpO₂ sensors are attached to the skin in the regions of superficial artery and vein (010) and posterior auricular artery and vein around the ear (011 of FIG. 1C) (temporal region of the head). This sensor system is less vulnerable to motion artifacts hence capable of producing high quality PPG signals under motion conditions such as running and exercising.

An apparatus and method to detect a blood flow signal free from a motion artifact, and a stress test apparatus using the same, enhance data reliability of the blood flow signal by removing the motion artifact from the blood flow signal detected by photo-plethysmography. The apparatus to detect the blood flow signal includes a base pattern correlation coefficient calculating unit to determine peak points in the blood flow signal sensed from a body of an examinee using a blood flow sensing unit, and to calculate correlation coefficients of each peak point using a predetermined base pattern, and a motion artifact processing unit to determine the motion artifact using the calculated correlation coefficients and to remove the motion artifact from the blood flow signal. Thus, reliability of the blood flow signal is enhanced by effectively removing the motion artifact from the blood flow signal detected by the photo-plethysmography.

Methods and devices are provided for reducing motion artifacts when measuring blood oxygen saturation. A portion of the light having the first wavelength, a portion of light having the second wavelength and a portion of the light having the third wavelength are received. A first signal is produced based on the received portion of light having the first wavelength. Similarly, a second signal is produced based on the received portion of light having the second wavelength, and a third signal is produced based on the received portion of light having the third wavelength. A difference between the second signal and the first signal is determined, wherein the difference signal is first plethysmography signal. Similarly, a difference is determined between the third signal and the first signal to produce a second plethysmography signal. Blood oxygen saturation is then estimated using the first and second plethysmography signals.

An algorithm for removing motion artifacts from the PPG signal in the time domain to determine heart rate is disclosed. A device for determining a heart rate of a user can include a heart rate sensor configured to generate heart rate signals when positioned on or adjacent to a user's skin, an accelerometer configured to generate one or more acceleration signals, and processing circuitry configured to remove, in a time domain, motion artifacts from the heart rate signals based on the acceleration signals. In some examples, the removal of motion artifacts can also be based on mean-centered, variance-scaled integrated acceleration signals. In some examples, the processing circuitry can be configured to remove motion artifacts using a least squares algorithm to identify a best representation of acceleration and integrated acceleration signals in the heart rate signals.